4 documents

Read All
08:00 , Jan 27, 2014 |  BC Week In Review  |  Company News

Celesio deal

Investor Elliott Asset Management LLC has increased its Celesio stake to 24.08% from 19.11% as of Nov. 19, 2013. In October, Healthcare services and IT company McKesson Corp. (NYSE:MCK, San Francisco, Calif.) announced plans to...
Read More
08:00 , Nov 4, 2013 |  BC Week In Review  |  Company News

Celesio, Franz Haniel & Cie., McKesson Corp. deal

Healthcare services and IT company McKesson plans to acquire Haniel's 50.01% stake in Celesio for €23 per share and launch public tender offers for the remaining publicly traded shares at €23 per share and outstanding...
Read More
08:00 , Oct 30, 2006 |  BC Week In Review  |  Company News

Celesio AG, Ipsen sales and marketing update

Celesio's Movianto Group unit will exclusively distribute IPN's Somatuline Autogel in the U.K.. The extended-release injectable formulation of the somatostatin analog lanreotide is approved in the EU and Canada to treat acromegaly due to pituitary...
Read More
07:00 , Oct 9, 2006 |  BC Week In Review  |  Company News

Celesio AG, TopoTarget sales and marketing update

Celesio's Movianto Group (Stuttgart, Germany) business unit will distribute TOPO's Savene dexrazoxane in Europe. The topoisomerase II inhibitor is approved to treat accidental extravasation of anthracycline chemotherapeutics. Celesio AG (FSE:CLS1), Stuttgart, Germany   TopoTarget A/S...
Read More